Research Progress on Chitosan Microneedle Arrays in Transdermal Drug Delivery

Haonan Li,1 Jie Cui,1 Tianyi Zhang,2 Fengli Lin,2 Guimin Zhang,1,3 Zhong Feng1– 3 1College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People’s Republic of China; 2Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People’s Republic of China; 3Lunan Pharmaceutical Group Co., Ltd., Linyi, Shandong, 276000, People’s Republic of ChinaCorrespondence: Zhong Feng; Guimin Zhang, College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People’s Republic of China, Email [email protected]; [email protected]: As a type of transdermal drug delivery system (TDDS), Microneedles (MNs) have garnered significant attention from researchers due to their ability to penetrate the stratum corneum (SC) of the skin, enhance drug permeability and bioavailability, avoid first-pass metabolism, and cause minimal damage to the skin. This makes them particularly suitable for localized transdermal drug delivery. Dissolvable microneedles (DMNs) can encapsulate sensitive particles, provide high drug-loading capacity, and possess biodegradability and biocompatibility, attracting extensive research interest. Chitosan (CS) has been selected as the matrix for manufacturing DMNs due to its excellent properties, including not eliciting an immune response in vivo and having active functional groups such as hydroxyl and amino groups that allow for modifications to impart appropriate mechanical strength and functionality to DMNs for specific applications. This paper provides a comprehensive review of the research status of various chitosan-based microneedles (CSMNs), explores the mechanisms of their dissolution in vivo, and discusses their applications in promoting wound healing, delivering macromolecular drugs, vaccine delivery, and anti-tumor therapies.Keywords: transdermal drug delivery, microneedles, dissolvable microneedles, chitosan, chitosan-based microneedles

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2024-12-01
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Research Progress on Chitosan Microneedle Arrays in Transdermal Drug Delivery

SHILAP Revista de lepidopterología
Advancements in Transdermal Drug Delivery
article

Research Progress on Chitosan Microneedle Arrays in Transdermal Drug Delivery

article en

Abstract

Haonan Li,1 Jie Cui,1 Tianyi Zhang,2 Fengli Lin,2 Guimin Zhang,1,3 Zhong Feng1– 3 1College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People’s Republic of China; 2Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People’s Republic of China; 3Lunan Pharmaceutical Group Co., Ltd., Linyi, Shandong, 276000, People’s Republic of ChinaCorrespondence: Zhong Feng; Guimin Zhang, College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, 250355, People’s Republic of China, Email [email protected]; [email protected]: As a type of transdermal drug delivery system (TDDS), Microneedles (MNs) have garnered significant attention from researchers due to their ability to penetrate the stratum corneum (SC) of the skin, enhance drug permeability and bioavailability, avoid first-pass metabolism, and cause minimal damage to the skin. This makes them particularly suitable for localized transdermal drug delivery. Dissolvable microneedles (DMNs) can encapsulate sensitive particles, provide high drug-loading capacity, and possess biodegradability and biocompatibility, attracting extensive research interest. Chitosan (CS) has been selected as the matrix for manufacturing DMNs due to its excellent properties, including not eliciting an immune response in vivo and having active functional groups such as hydroxyl and amino groups that allow for modifications to impart appropriate mechanical strength and functionality to DMNs for specific applications. This paper provides a comprehensive review of the research status of various chitosan-based microneedles (CSMNs), explores the mechanisms of their dissolution in vivo, and discusses their applications in promoting wound healing, delivering macromolecular drugs, vaccine delivery, and anti-tumor therapies.Keywords: transdermal drug delivery, microneedles, dissolvable microneedles, chitosan, chitosan-based microneedles

SHILAP Revista de lepidopterología
Good health and well-being
Openalex Percentile: Top 58%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Research Progress on Chitosan Microneedle Arrays in Transdermal Drug Delivery · SHILAP Revista de lepidopterología (2024) | TGRS Research Map | TGRS